Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Metal Hip Class II Status Not Supported By Existing Data; FDA Rejects Petition

This article was originally published in The Gray Sheet

Executive Summary

Inadequate clinical data are available to justify reclassification of metal-on-metal, semi-constrained hip joint prostheses from Class III to Class II, FDA says

You may also be interested in...



Round Two For Metal-On-Metal Hip Implant Reclassification Effort

Orthopedic industry members are taking a second shot at relieving some regulatory burdens for metal-on-metal hip implants

Round Two For Metal-On-Metal Hip Implant Reclassification Effort

Orthopedic industry members are taking a second shot at relieving some regulatory burdens for metal-on-metal hip implants

Metal Hip PMAs Low Priority, But Data Lacking for Class II Status, Panel Says

Metal-on-metal hip joint prostheses lack adequate long-term follow-up data to justify downclassification to Class II, FDA's Orthopedic and Rehabilitation Devices Advisory Panel determined at an Aug. 8 meeting in Gaithersburg, Maryland.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017122

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel